184 related articles for article (PubMed ID: 3040863)
1. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.
Farrar WL; Evans SW; Rapp UR; Cleveland JL
J Immunol; 1987 Sep; 139(6):2075-80. PubMed ID: 3040863
[TBL] [Abstract][Full Text] [Related]
2. Regulation of proliferation in a murine colony-stimulating factor-dependent myeloid cell line: superinduction of c-fos by the growth inhibitor 8-Br-cyclic adenosine 3':5' monophosphate.
Harel-Bellan A; Farrar WL
J Cell Biochem; 1988 Nov; 38(3):145-53. PubMed ID: 3068231
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels.
Anastassiou ED; Paliogianni F; Balow JP; Yamada H; Boumpas DT
J Immunol; 1992 May; 148(9):2845-52. PubMed ID: 1374102
[TBL] [Abstract][Full Text] [Related]
4. IL-1 signal transduction pathways. I. Two functional IL-1 receptors are expressed in T cells.
Muñoz E; Zubiaga AM; Sims JE; Huber BT
J Immunol; 1991 Jan; 146(1):136-43. PubMed ID: 1845804
[TBL] [Abstract][Full Text] [Related]
5. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ornithine decarboxylase activity by IL-2 and cyclic AMP.
Farrar WL; Vinocour M; Cleveland JL; Harel-Bellan A
J Immunol; 1988 Aug; 141(3):967-71. PubMed ID: 2840461
[TBL] [Abstract][Full Text] [Related]
8. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
10. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
Kumagai N; Benedict SH; Mills GB; Gelfand EW
J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
[TBL] [Abstract][Full Text] [Related]
11. The role of the accessory cell in mitogen-stimulated human T cell gene expression.
Kern JA; Reed JC; Daniele RP; Nowell PC
J Immunol; 1986 Aug; 137(3):764-9. PubMed ID: 3088109
[TBL] [Abstract][Full Text] [Related]
12. Two differential effects of cyclic adenosine 3',5'-monophosphate on IL-5 production by antigen-specific human T cell line.
Kaminuma O; Mori A; Ogawa K; Wada K; Kikkawa H; Naito K; Suko M; Okudaira H
J Pharmacol Exp Ther; 1997 Oct; 283(1):345-9. PubMed ID: 9336342
[TBL] [Abstract][Full Text] [Related]
13. Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation.
Lingk DS; Chan MA; Gelfand EW
J Immunol; 1990 Jul; 145(2):449-55. PubMed ID: 2164063
[TBL] [Abstract][Full Text] [Related]
14. Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.
Reed JC; Alpers JD; Scherle PA; Hoover RG; Nowell PC; Prystowsky MB
Oncogene; 1987 May; 1(2):223-8. PubMed ID: 3501855
[TBL] [Abstract][Full Text] [Related]
15. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
Cleveland JL; Rapp UR; Farrar WL
J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate.
Knudsen PJ; Dinarello CA; Strom TB
J Immunol; 1986 Nov; 137(10):3189-94. PubMed ID: 3021848
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
[TBL] [Abstract][Full Text] [Related]
18. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 induces protein tyrosine phosphorylation in T cells.
Muñoz E; Zubiaga A; Huang C; Huber BT
Eur J Immunol; 1992 Jun; 22(6):1391-6. PubMed ID: 1376256
[TBL] [Abstract][Full Text] [Related]
20. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
Klemsz MJ; Justement LB; Palmer E; Cambier JC
J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
